Invivyd, Inc.
Public company- Headquarters
- NEW HAVEN, Connecticut
- Industry
- Biotechnology
- Ticker
- IVVD
- CIK
- 0001832038
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CEOMarc Elia | Sep 1, 2026 | Appointed |
| Lead Independent DirectorAjay Royan | Sep 1, 2026 | Appointed |
| directorIan Sheffield | Sep 1, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- IRulya Therapeutics Inc.
CEO departs: Dirk Thye, M.D.
- ANAVEX LIFE SCIENCES CORP.
CEO appointed: Terrie Kellmeyer, Ph.D.
- RECURSION PHARMACEUTICALS, INC.
Chair of the Board appointed: Fred Hassan
- Vir Biotechnology, Inc.
Class III director appointed: Suzanne Topalian, M.D.
- Executive appointment
CEO appointed: Marc Elia
Marc Elia was named Chief Executive Officer of Invivyd, Inc., effective August 30, 2026. Marc Elia succeeds William Duke, Jr.. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 1, 2026Role: Chief Executive Officer
- Executive appointment
Lead Independent Director appointed: Ajay Royan
Ajay Royan was named Lead Independent Director of Invivyd, Inc., effective August 30, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 1, 2026Role: Lead Independent Director
- Executive appointment
director appointed: Ian Sheffield
Ian Sheffield was named director of Invivyd, Inc., effective August 30, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 1, 2026Role: director
Last verified Nov 8, 2026